English | Español
Patient Daily | Feb 6, 2026

Amgen declines FDA request to withdraw rare disease drug Tavneos
Patient Daily | Feb 6, 2026

Novartis maintains acquisition focus while reporting strong financial results
Patient Daily | Feb 6, 2026

GSK focuses on complications from obesity rather than GLP-1 drugs
Patient Daily | Feb 6, 2026

Eli Lilly sees opportunity as Novo Nordisk's oral Wegovy expands obesity drug market
Patient Daily | Feb 6, 2026

Congressman questions transparency of FDA's priority voucher program
Patient Daily | Feb 6, 2026

Eli Lilly expands tirzepatide trials into immunology with combination therapies
Patient Daily | Feb 6, 2026

AbbVie stresses growth beyond immunology as Skyrizi and Rinvoq lead 2025 sales
Patient Daily | Feb 6, 2026

Rare disease drug development sees growth amid regulatory changes

Trending
+ Pharmaceuticals
Patient Daily | May 7, 2026

FARE launches new PSA featuring Joshua Jackson to raise food allergy awareness
Patient Daily reports | May 8, 2026

Columbia Breathe Free patient in 5.0 Google review: ‘I am already feeling like my nose is just moving air better’
+ Pharmaceuticals
Patient Daily | May 7, 2026

Sanofi requests removal of Tzield from CNPV program after Høeg gets involved
+ Regulatory
Patient Daily | May 11, 2026

HEAL Network Director Parente on 340B program: 'Patients often see none of the discount'